Cargando…
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
The expression of the Adenovirus serotype 5 (Ad5) E1A oncogene sensitizes tumor cells to natural killer (NK) cell–mediated killing and tumor rejection in vivo. These effects are dependent on the ability of E1A to bind the transcriptional coadaptor protein p300. To test the hypothesis that E1A up-reg...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213342/ https://www.ncbi.nlm.nih.gov/pubmed/16314433 http://dx.doi.org/10.1084/jem.20050240 |
_version_ | 1782148876499681280 |
---|---|
author | Routes, John M. Ryan, Sharon Morris, Kristin Takaki, Rayna Cerwenka, Adelheid Lanier, Lewis L. |
author_facet | Routes, John M. Ryan, Sharon Morris, Kristin Takaki, Rayna Cerwenka, Adelheid Lanier, Lewis L. |
author_sort | Routes, John M. |
collection | PubMed |
description | The expression of the Adenovirus serotype 5 (Ad5) E1A oncogene sensitizes tumor cells to natural killer (NK) cell–mediated killing and tumor rejection in vivo. These effects are dependent on the ability of E1A to bind the transcriptional coadaptor protein p300. To test the hypothesis that E1A up-regulates ligands recognized by the NKG2D-activating receptor, we stably transfected the highly tumorigenic mouse fibrosarcoma cell line MCA-205 with Ad5-E1A or a mutant form of E1A that does not interact with p300 (E1A-Δp300). Ad5-E1A, but not E1A-Δp300, up-regulated the expression of the NKG2D ligand retinoic acid early inducible (RAE)-1, but not murine ULBP-like transcript 1, another NKG2D ligand, in four independently derived MCA-205 transfectants. The up-regulation of RAE-1 by E1A targeted MCA-205 tumor cells to lysis by NK cells, resulting in NKG2D-dependent tumor rejection in vivo. Moreover, the up-regulation of NKG2D ligands by E1A was not limited to mouse tumor cells, as E1A also increased the expression of NKG2D ligands on primary baby mouse kidney cells, human MB435S breast cancer cells, and human H4 fibrosarcoma cells. |
format | Text |
id | pubmed-2213342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22133422008-03-11 Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection Routes, John M. Ryan, Sharon Morris, Kristin Takaki, Rayna Cerwenka, Adelheid Lanier, Lewis L. J Exp Med Article The expression of the Adenovirus serotype 5 (Ad5) E1A oncogene sensitizes tumor cells to natural killer (NK) cell–mediated killing and tumor rejection in vivo. These effects are dependent on the ability of E1A to bind the transcriptional coadaptor protein p300. To test the hypothesis that E1A up-regulates ligands recognized by the NKG2D-activating receptor, we stably transfected the highly tumorigenic mouse fibrosarcoma cell line MCA-205 with Ad5-E1A or a mutant form of E1A that does not interact with p300 (E1A-Δp300). Ad5-E1A, but not E1A-Δp300, up-regulated the expression of the NKG2D ligand retinoic acid early inducible (RAE)-1, but not murine ULBP-like transcript 1, another NKG2D ligand, in four independently derived MCA-205 transfectants. The up-regulation of RAE-1 by E1A targeted MCA-205 tumor cells to lysis by NK cells, resulting in NKG2D-dependent tumor rejection in vivo. Moreover, the up-regulation of NKG2D ligands by E1A was not limited to mouse tumor cells, as E1A also increased the expression of NKG2D ligands on primary baby mouse kidney cells, human MB435S breast cancer cells, and human H4 fibrosarcoma cells. The Rockefeller University Press 2005-12-05 /pmc/articles/PMC2213342/ /pubmed/16314433 http://dx.doi.org/10.1084/jem.20050240 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Routes, John M. Ryan, Sharon Morris, Kristin Takaki, Rayna Cerwenka, Adelheid Lanier, Lewis L. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title | Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title_full | Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title_fullStr | Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title_full_unstemmed | Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title_short | Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection |
title_sort | adenovirus serotype 5 e1a sensitizes tumor cells to nkg2d-dependent nk cell lysis and tumor rejection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213342/ https://www.ncbi.nlm.nih.gov/pubmed/16314433 http://dx.doi.org/10.1084/jem.20050240 |
work_keys_str_mv | AT routesjohnm adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection AT ryansharon adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection AT morriskristin adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection AT takakirayna adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection AT cerwenkaadelheid adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection AT lanierlewisl adenovirusserotype5e1asensitizestumorcellstonkg2ddependentnkcelllysisandtumorrejection |